Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brand-to-brand nonmedical switching among interleukin-17 inhibitors or other biologics: Implications of a formulary change.

Journal of managed care & specialty pharmacy·2025

Same author

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance.

Journal of managed care & specialty pharmacy·2020

Same author

Capture of biologic and biosimilar dispensings in a consortium of U.S.-based claims databases: Utilization of national drug codes and Healthcare Common Procedure Coding System modifiers in medical claims.

Pharmacoepidemiology and drug safety·2019

Same author

Liquid nitrogen spray cryotherapy for dysphagia palliation in patients with inoperable esophageal cancer.

Gastrointestinal endoscopy·2018

Same author

Toxic Injury to the Gastrointestinal Tract After Ipilimumab Therapy for Advanced Melanoma.

The Journal of the American Osteopathic Association·2018

Same author

Endosonographic examination of thyroid gland among patients with nonthyroid cancers.

Endoscopic ultrasound·2016

Search research articles

Related Experiment Video

Updated: Mar 9, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer.

Benjamin Shepard¹, Leon Yoder², Cynthia Holmes³

¹Department of Gastroenterology, Oklahoma State University, Tulsa, OK.

ACG Case Reports Journal

|December 24, 2016

Summary

Germline mutations in the CDH1 gene significantly increase hereditary diffuse gastric cancer risk. Prophylactic total gastrectomy before age 40 is recommended for mutation carriers due to ineffective endoscopic surveillance.

More Related Videos

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Published on: December 27, 2024

Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma

Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma

Published on: August 9, 2016

Related Experiment Videos

Last Updated: Mar 9, 2026

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Laparoscopic Radical Gastrectomy for Remnant Gastric Cancer

Published on: October 31, 2025

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Single Incision Plus One Port Laparoscopic Proximal Gastrectomy with Double Channel Anastomosis for Gastric Cancer Treatment

Published on: December 27, 2024

Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma

Intraoperative Gastroscopy for Tumor Localization in Laparoscopic Surgery for Gastric Adenocarcinoma

Published on: August 9, 2016

Area of Science:

Oncology
Genetics
Gastroenterology

Background:

Hereditary diffuse gastric cancer (HDGC) is linked to germline mutations in the CDH1 gene, which encodes E-cadherin.
These mutations are associated with early-onset gastric cancer, with a mean diagnosis age of 37 years.

Observation:

Individuals with CDH1 mutations face a high lifetime risk of gastric cancer: 67% for men and 83% for women by age 80.
Current endoscopic surveillance methods appear largely ineffective for detecting cancer in HDGC mutation carriers.

Findings:

Germline CDH1 mutations are a significant risk factor for developing diffuse gastric cancer.
The lifetime risk of gastric cancer is substantially elevated in carriers of these mutations.

Implications:

Prophylactic total gastrectomy is a recommended preventative measure for individuals identified with germline CDH1 mutations.
Surgical intervention should be considered between the ages of 18 and 40 years for mutation carriers to mitigate cancer risk.